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Abstract
Background: Recently, we observed that small-intestinal ischemia and reperfusion was found to entail a rapid loss of
apoptotic and necrotic cells. This study was conducted to investigate whether the observed shedding of ischemically
damaged epithelial cells affects IR induced inflammation in the human small gut.
Methods and Findings: Using a newly developed IR model of the human small intestine, the inflammatory response was
studied on cellular, protein and mRNA level. Thirty patients were consecutively included. Part of the jejunum was subjected
to 30 minutes of ischemia and variable reperfusion periods (mean reperfusion time 120 (611) minutes). Ethical approval and
informed consent were obtained. Increased plasma intestinal fatty acid binding protein (I-FABP) levels indicated loss in
epithelial cell integrity in response to ischemia and reperfusion (p,0.001 vs healthy). HIF-1a gene expression doubled
(p=0.02) and C3 gene expression increased 4-fold (p=0.01) over the course of IR. Gut barrier failure, assessed as LPS
concentration in small bowel venous effluent blood, was not observed (p=0.18). Additionally, mRNA expression of HO-1, IL-
6, IL-8 did not alter. No increased expression of endothelial adhesion molecules, TNFa release, increased numbers of
inflammatory cells (p=0.71) or complement activation, assessed as activated C3 (p=0.14), were detected in the reperfused
tissue.
Conclusions: In the human small intestine, thirty minutes of ischemia followed by up to 4 hours of reperfusion, does not
seem to lead to an explicit inflammatory response. This may be explained by a unique mechanism of shedding of damaged
enterocytes, reported for the first time by our group.
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Introduction
Recently, we demonstrated the ability of the human small
intestine to rapidly restore its epithelial architecture after massive
epithelial sloughing and gut barrier damage in response to a thirty
minutes ischemic episode and variable reperfusion periods.[1]
Interestingly, analysis of the reperfused intestinal segment
demonstrated that the epithelial brush border and epithelial tight
junctions were restored within the first hour of reperfusion.[1]
The presence of apoptosis or cellular damage in reperfused
ischemic organs has cardinal implications in the pathogenesis of
ischemia reperfusion (IR).[2,3] Massive apoptosis and subsequent
necrosis are involved in the induction of inflammation after organ
ischemia. This notion is based on the observation that therapeutic
strategies aimed at preventing IR induced apoptosis can
ameliorate IR induced inflammation.[4–7] Numerous experimen-
tal studies have shown that the inflammatory response following
IR mediates the development of additional reperfusion injury,
further compromising organ function.[4,8–12] Different strategies
aimed at preventing IR induced inflammation can effectively
reduce organ damage.[13]
The inflammatory response induced by IR is essentially
characterized by different contributors. Early after cellular injury
various cytokines, such as tumor necrosis factor-a, interleukin-1, -
6, -8 or -10 and others, are expressed.[14,15] Together with the
rapid expression of adhesion molecules by activated endothelial
cells, the activation, adhesion and sequestration of polymorpho-
nuclear neutrophils (PMN) into the affected tissue is induced.[16]
Infiltrating PMN contribute substantially to IR induced inflam-
mation, by locally releasing myeloperoxidase (MPO) or generating
reactive oxygen species.[10,17] Additionally the complement
system is activated, thereby triggering the formation of reactive
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additional PMN chemotaxis and cause organ damage.[18,19]
Complement activation will lead to cell damage by membrane
attack complex (MAC) formation.[9,19] Normally, under healthy
conditions, these innate immune constituents protect the organism
from harm by orchestrating a well mounted attack on invading
microorganisms, but when faced with extensive I/R injury,
sufficient means of control seem absent. In this respect,
interventions aimed at preventing complement activation,[8]
MAC formation,[20] expression of adhesion molecules[21] or
PMN sequestration[22,23] all prevent excessive reperfusion injury.
The presence of apoptotic and necrotic cells following ischemia
reperfusion of the small intestine appears to be of critical
importance in the development of an inflammatory reaction that
contributes to tissue injury. From this we hypothesized that the
remarkable ability of the human small intestine to effectively shed
apoptotic cells, is a way of losing an important endogenous
inflammatory trigger. This may serve as a unique intestinal rescue
mechanism, which potentially attenuates the development of an
intense IR induced inflammatory reaction. Therefore, we studied
time related characteristics of IR induced inflammation of the
human small intestine in a newly developed human ischemia
reperfusion model of the jejunum. The results indicate that
reperfused ischemic jejunum effectively discards apoptotic and
damaged epithelium, restores the epithelial gut barrier and




The study was approved by the Maastricht University Medical
Center ethical committee. Written consent of all patients was
obtained before inclusion. Consecutively included patients were
scheduled to undergo pancreatic surgery; twenty eight underwent
a pylorus preserving pancreatico-duodenectomy (modified Whip-
ple’s procedure) for benign or malignant pancreatic disease and
two underwent a Frey’s procedure for chronic pancreatitis. During
pancreatico-duodenectomy a variable length of jejunum is usually
resected in continuity with the specimen. Similarly, in creating a
Roux-limb for the pancreatico-jejunostomy in Frey’s procedure, it
is often necessary to resect a small segment of jejunum. We took
advantage of this, which enabled us to study IR induced cell
damage in a harmless human jejunal IR model. To that purpose,
the most distal part of the jejunum to be resected with the Whipple
specimen, or the most proximal part of the Roux-limb to be used
as a pancreatico-jejunostomy in the Frey’s procedure, was used to
isolate a 6 cm segment of jejunum. The jejunum of all patients was
carefully checked for any signs of underlying pathology and
inflammation during operation and before the start of the IR
procedure. Due to an incomplete reperfusion 2 patients were later
excluded from further analysis, all having had a modified
Whipple’s procedure.
Study model and blood sampling
The first part of surgery (opening of the abdominal wall,
installation of a large self-retaining retractor and exploration for
metastases and localization of the major anatomical structures and
tumor) was according to standard procedures. From this moment
the 6 cm part of jejunum, which was going to be studied, was
identified and care was taken that the vasculature of the studied
jejunum consisted of 1 central mesenteric arteriole and venule.
This was achieved as described before.[1,24] In brief, clamping
and cutting of all collateral mesenterial vessels to the studied
segment of jejunum, using Ultracision Harmonic Ace (Johnson&-
Johnson, cat. no. ACE23P, Amersfoort, the Netherlands).
Thereafter, the segment of jejunum was further isolated by
transsection at both ends with a linear cutting stapler (GIA 6038S,
Covidien, Zaltbommel, the Netherlands). The isolated jejunum
was then subjected to 30 minutes ischemia using 2 a-traumatic
vascular clamps, which are placed over the mesentery in opposed
directions to ensure complete clamping (Bulldog, Aesculap, cat.
no. BH013R, Tuttlingen, Germany). The isolated ischemic
jejunum was subsequently kept in the abdominal cavity to
guarantee warm ischemia. After half an hour of ischemia, one
third (2 cm) of the isolated ischemic jejunum was resected to study
early phenomena during ischemia. Reperfusion was initiated by
removal of the clamps. Adequacy of reperfusion was confirmed by
the gut regaining color and restoration of peristalsis. Subsequently,
the venous outflow was sampled. A further segment of isolated
jejunum (2 cm) was resected similarly after 25 minutes of
reperfusion to study early phenomena during reperfusion. The
last part of studied jejunum was resected from 60 minutes after
reperfusion onwards, to investigate late phenomena during
reperfusion. At the time the last isolated reperfused segment of
jejunum was obtained for the study, also 2 cm of jejunum, which
had not been isolated and remained untreated during surgery, was
resected using a linear cutting stapler. This tissue was used as
internal control tissue: it was from the same patient and
experienced similar surgical handling as the isolated jejunum,
while it was not subjected to IR. Arterial blood was sampled
preoperatively, before the isolated jejunum was subjected to
ischemia, immediately upon reperfusion and every half hour
during reperfusion until the last part of the isolated jejunum was
collected at the end of the study protocol. Simultaneous with the
second (i.e. before ischemia) and every next arterial blood sample,
blood was drawn from the venule draining the isolated jejunal
segment by direct puncture to assess concentration gradients
across the isolated jejunal segment. All blood samples were directly
transferred to pre-chilled EDTA vacuum tubes (BD vacutainer,
Becton Dickinson Diagnostics, Aalst, Belgium) and kept on ice. At
the end of the study all blood samples were centrifuged at
4000 rpm, 4uC for 15 minutes to obtain plasma. Plasma was kept
on ice and immediately stored in aliquots at 280uC until analysis.
The total reperfusion time was determined by the duration of the
surgical procedure, with a maximum of 240 minutes. Reperfused
ischemic intestine samples were obtained from every patient
(n=28). Healthy jejunum samples, serving as internal controls,
were obtained from 12 patients.
Immunohistochemistry
Paraffin-embedded sections (4 mm) were prepared from healthy
and the final IR jejunum sample. These sections were stained
using haematoxylin and eosin or immunostained for endothelial
adhesion molecules E-selectin (CD-62-E, monoclonal antibody
ENA1, kindly provided by Hycult Biotechnology (Hbt, Uden, the
Netherlands)), intercellular adhesion molecule-1 (ICAM-1, mono-
clonal antibody HM1, Hbt) and mucosal vascular addressin cell
adhesion molecule 1 (MADCAM-1, monoclonal antibody 314G8,
Hbt), neutrophils by myeloperoxidase staining (polyclonal anti-
body, A0398, DakoCytomation, Glostrup, Denmark) or human
neutrophil defensin 1–3 (monoclonal antibody, D21, Hbt) and
complement component C3c (A0062, DakoCytomation). Sections
were deparaffinized, rehydrated and blocked for 1 hour at room
temperature using 5% BSA in phosphate buffered saline (PBS) or
tris buffered saline (TBS) for HM1 and MPO. Properly diluted
primary antibodies were incubated in PBS or TBS supplemented
with 0.1% BSA for 1 hour at room temperature. After washing,
Ischemia Reperfusion in Man
PLoS ONE | www.plosone.org 2 September 2009 | Volume 4 | Issue 9 | e7045specific antibody binding was detected using specific peroxidase
conjugated secondary antibodies (Jackson Immunoresearch, West
Grove, PA) or a biotinylated swine anti rabbit secondary antibody
(E0432, DakoCytomation) for detecting MPO specific binding.
Next, signal enhancement was achieved by peroxidase conjugated
avidin biotin complexes. Staining was visualized by 3-amino-9-
ethylcarbazole (AEC) followed by a hematoxylin (Sigma, St. Louis,
MO) nuclear counterstaining. Microscopic analysis of several high
power fields (n=5) from different paraffin embedded tissue
samples was carried out by a blinded observer.
ELISA
Arteriovenous concentration differences of plasma Intestinal-
Fatty Acid Binding Protein (I-FABP) levels were determined by
Enzyme-Linked ImmunoSorbent Assay (ELISA) before and after
ischemia to measure intestinal mucosal cell damage.[25] Plasma I-
FABP was determined in all samples, collected at pre-fixed time
points.
The I-FABP ELISA (HK406, Hbt) was performed according to
the manufacturer’s guidelines. Myeloperoxidase (MPO) was
measured in tissue samples (healthy vs the final IR jejunum
sample) that were homogenized according to the later described
Western blot protocol. MPO was measured using a commercially
available solid-phase ELISA kit based on the sandwich principle
(Hbt) in aliquots containing equal amounts (10 mg) of total protein.
The assay was performed in accordance with the manufacturer’s
guidelines.
Arteriovenous concentration differences in plasma tumor
necrosis factor-a (TNFa) levels were determined by ELISA before
and after ischemia as well as during reperfusion. The TNFa
ELISA was performed as described before.[26] Arteriovenous
concentration differences in plasma lipopolysacharide (LPS) levels
were determined using a Limulus Amebocyte Lysate (LAL) assay
before and after ischemia as well as during reperfusion. The LAL
assay (HIT 302, Hbt) was performed in accordance with the
manufacturer’s guidelines. Plasma LPS was determined in all
samples, collected at pre-fixed time points.
Western Blot
Western blot analyses for human C3 deposition on reperfused
ischemic tissue samples and healthy controls was performed as
described before, with minor modifications.[4] Jejunal samples
were homogenized in lysis buffer (200 mM NaCl, 10 mM Tris
base, 5 mM EDTA, 10% Glycerin, 1 mM PMSF, 0.1 U/ml
Aprotinin and 1 mg/ml Leupeptin). Tissue homogenates were
centrifuged. Protein concentrations of the different lysates were
determined using Bradford analyses. Aliquots containing equal
amounts (10 mg) of total protein were heated and reduced,
transferred to an 8% SDS-polyacrylamide gel and blotted on an
Immobilon-P Polyvinylidene Difluoride (PVDF) membrane (Milli-
pore, Bedford, MA). Blocking was performed in phosphate
buffered saline (PBS) containing 5% bovine serum albumin and
0.1% Tween-20 (Sigma). C3 was detected in PBS 0.1% BSA 0.1%
Tween-20 after overnight incubation of the properly diluted rabbit
anti human C3c (A0062, DakoCytomation, Glostrup, Denmark).
Binding of the primary antibody was detected using a biotinylated
secondary antibody to rabbit IgG (E0353, Dako) and streptavidin
conjugated peroxidase. Positive bands were visualized using
chemiluminescence (Supersignal (pico:femto 9:1), Pierce, Rock-
ford, IL).
Real-Time Quantitative - PCR analysis
Total RNA was extracted from healthy and all IR damaged
jejunum samples using a SV Total RNA Isolation System
according to manufacturer’s guidelines (Promega, Madison, WI).
Total cDNA was synthesized with oligo (dT) primers and Molony
murine leukemia virus reverse transcriptase. Specific primers
(Sigma) for amplification of hemoxygenase-1, hypoxia inducible
factor 1-a (HIF-1a), interleukin-6 and -8, TNFa and complement
component C3 specific cDNA were designed (Table 1) using the
Primer Express software package (Applied Biosystems, Foster City,
CA) and tested for amplification of contaminating genomic DNA.
To minimize the risk of genomic amplification the primers were
positioned on different exons. Primer concentrations were
optimalized and dilution curves were made from human liver
cDNA standard pool to ensure an exponential Taqman amplifi-
cation for each primer set. After normalization to endogenous
reference genes, RPLP0 and cyclophylin-A, the level of expression
of different proteins in healthy or IR damaged samples was
determined by the comparative DDCT method of relative
quantification. Primer specifications are listed in Table 1.
Statistical analysis
Dataareexpressedasmeans6SEMandwereanalyzedbyeither
paired or unpaired two-tailed Student’s t-test depending on sample
collection. Bonferroni’s multiple comparison test was used (after
significant repeated measures ANOVA) to compare I-FABP or LPS
arteriovenousconcentrationdifferencesintime.Datawere analyzed
using Prism 4.01 for Windows (Graphpad Software, San Diego,
CA). A p-value#0.05 was considered statistically significant.










Cycophilin A 3-CTCGAATAAGTTTGACTTGTGTTT-5 5-CTAGGCATGGGAGGGAACA-3
doi:10.1371/journal.pone.0007045.t001
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Patient outcome and reperfusion period
The mean (6 SEM) age of included patients (n=28) was 65
(62) years and 64% were male. Isolated jejunum samples were
subjected to 30 minutes of ischemia followed by a mean total
reperfusion time of 120 (611) minutes (Fig. 1).
Intestinal epithelial damage
Epithelial cell integrity was lost in response to 30 minutes of
ischemia followed by various periods of reperfusion. This was
illustrated by increased plasma I-FABP levels in the venous
outflow of the reperfused jejunum, when compared to arterial
circulating levels and I-FABP levels prior to the IR period (*
p,0.001. Fig. 2A). As described by Derikx et al. rapid sloughing of
intestinal epithelial cells, during the first thirty minutes of
reperfusion, was observed. Shedding of epithelial cells was
followed by a full and rapid repair of the damaged intestinal
epithelial barrier within the first hour of reperfusion (Fig. 2B–
C).[1]
Plasma LPS levels following IR
Disruption of the gut barrier may lead to translocation of
microbiota and pro-inflammatory microbial products, such as
endotoxin associated with gram negative bacteria (lipopolysachar-
ide (LPS)). Therefore we assessed the translocation of LPS
following the rapid and temporary disruption of the epithelial
lining in response to IR observed in our model.[1] LPS
translocation from the intestinal lumen was assessed by measuring
arterio-venous (AV) differences in LPS concentration across the
jejunal segment, using the LAL-assay. Surprisingly, no transloca-
tion of LPS (p=0.18, n=28) was detected at any time point
during reperfusion (Fig. 3). The temporary loss of gut wall integrity
observed during reperfusion, which is induced by massive
shedding of apoptotic epithelial cells, does not lead to the
translocation of LPS.
Stress response
In order to demonstrate a physiological response to anoxia and
to reperfusion stress, the mRNA expression profiles of hypoxia
inducible factor-1a (HIF-1a) and heme oxygenase-1 (HO-1) were
determined in healthy and IR damaged whole jejunum samples
(n=12). The HIF-1a expression, which regulates both physiologic
and pathophysiologic responses to ischemia, increased during
reperfusion (Table 2). In contrast, local mRNA expression of HO-
1 was unaltered by IR (Table 2).
Cytokine expression and endothelial activation
In order to assess the inflammatory reaction over the course of
IR, serial venous blood samples from the reperfused jejunum were
analyzed for different inflammatory markers. Additionally, the
cytokine response in reperfused whole jejunum tissue samples was
studied using Q-PCR. Endothelial cell activation was assessed by
immunohistochemistry on paraffin embedded whole jejunum
tissue samples before and after IR. No increase in TNFa protein
levels was detected in venous plasma samples, collected from the
isolated jejunum during the procedure; e.g. prior to ischemia,
directly after ischemia and every 30 minutes during reperfusion.
Figure 1. Reperfusion times. Distribution of maximal reperfusion
times of the isolated jejunum, following 30 minutes of ischemia (n=28).
doi:10.1371/journal.pone.0007045.g001
Figure 2. Epithelial cell damage. A) Arteriovenous concentration
differences of I-FABP (mesenteric venule minus radial artery) across the
isolated ischemic jejunal segment show rapid release of I-FABP into the
circulation at reperfusion (early R vs healthy * p,0.001). B) Shedding of
damaged epithelial cells into the intestinal lumen during the first thirty
minutes of reperfusion. C) Rapid repair of the intestinal epithelial lining,
observed following 1 hour of reperfusion.
doi:10.1371/journal.pone.0007045.g002
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differences in TNFa levels revealed no release of TNFa from
the gut (data not shown). In line, no increase in TNFa mRNA was
detected in IR damaged jejunum samples, when compared to
healthy jejunum controls from the same patient (Table 2).
mRNA expression of cytokines IL-6 (Table 2) and IL-8 (Table 2)
in response to IR differed widely and failed to show an increase
(n=12). The reperfusion length did not show any relation with
maximal IL-6 or IL-8 mRNA levels (data not shown).
Classic in the development of extensive IR damage is the early
expression of various adhesion molecules by activated endothelial
cells. Presence of E-selectin, ICAM-1 and MADCAM-1 were
analyzed using immunohistochemistry. Only 3 patient samples
demonstrated sporadic and minimal expression of E-selectin (data
not shown), ICAM-1 and MADCAM-1 (Fig. 4) following maximal
reperfusion.
Neutrophil infiltration and release of myeloperoxidase
Critical in the induction of reperfusion injury is the influx of
neutrophils as well as the release of their reactive constituents. The
presence of neutrophils was assessed using two different and widely
used neutrophil markers, human neutrophil defensin 1–3 (HNP1-
3) and myeloperoxidase (MPO), both stored in abundance in
azurophilic granules of neutrophils. Analysis of immunostained
tissue sections showed that the number of PMN in the reperfused
jejunum was similar to the number of PMN observed in healthy
control jejunum samples, as detected by immunohistochemical
analysis of HNP1-3 (Fig. 5A. p=0.90, n=10). In concordance,
analysis of whole jejunum samples for total MPO content by
ELISA revealed no increase in MPO protein in the reperfused
jejunum, when compared to healthy jejunum control samples
(Fig. 5B. I/R=101.0631.3 ng/mg vs Healthy=75.9632.6 ng/
mg. p=0.71, n=12). A small number of HNP1-3 positive PMN
were observed in cellular debris in the intestinal lumen (Fig. 5A.
Picture insert, broad arrow). The presence of these PMN in the
intestinal lumen was apparently of no considerable consequence to
the remaining jejunum.
Complement activation and expression in response to IR
of the jejunum
As a central mediator of IR induced inflammation, complement
is involved in the development of organ damage. Complement
component C3 is an important constituent of the complement
system, of which activation and deposition indicate complement
activity. Immunohistochemical analysis of healthy and IR
damaged jejunum sections revealed no increase in C3 deposition
in response to IR (Fig. 6A). In order to validate these data, human
C3 protein in total jejunum tissue after reperfusion was
additionally analyzed by Western blot. In keeping with the above
results, jejunum tissue specimens showed no increase in the
presence of activated C3 over the course of IR, when compared to
their healthy controls (Fig. 6B. I/R=3.0961.79 relative intensity
vs Healthy=1.00 relative intensity. p=0.14, n=12).
Interestingly, subsequent analysis of the response to IR by the
jejunum involving C3 mRNA, using Q-PCR analysis, clearly
detected C3 mRNA levels in both healthy and IR damaged whole
jejunum samples. During reperfusion, the amount of C3 specific
mRNA increased over 4 times in response to 30 minutes of
ischemia (p=0.01, Table 2).
Discussion
The present data demonstrate that rapid shedding of IR
damaged intestinal epithelial cells attenuates the development of a
classically observed vigorous inflammatory response in the
reperfused jejunum. When analyzed over a prolonged reperfusion
period, no increase in TNF-a, HO-1, IL-6, IL-8 gene expression,
expression of adhesion molecules, PMN influx or activation and
deposition of complement were observed. However, HIF1- a and
C3 gene expression were up-regulated during reperfusion. This
possibly illustrated an IR induced regenerative response, aimed at
intestinal barrier restoration and prevention of bacterial translo-
cation.
Development of IR induced organ damage is generally
described to be characterized by an excessive and vigorous
inflammatory response.[27] This inflammatory response is mainly
triggered by apoptosis of cells that cannot be resolved in time by
phagocytic cells and will become necrotic in time.[4] Such necrotic
cells are a source of damage associated molecular patterns
(DAMPS) or alarmins which recruit and activate innate immune
cells, aimed at restoration of homeostasis and tissue repair.[28,29]
However, in the context of ischemia and reperfusion such an
inflammatory reaction often results in additional tissue damage.
It has been demonstrated in the kidney as well as other organs
that IR induced inflammation and subsequent organ damage are
Figure 3. Tissue response to IR. Illustrative of rapid gut barrier
repair, no translocation of LPS could be detected during the IR
procedure. Translocation of LPS was calculated from arteriovenous
differences in LPS plasma levels across the isolated bowel segment
during reperfusion (D (V–A). p=0.18).
doi:10.1371/journal.pone.0007045.g003
Table 2. mRNA expression profiles in response to IR,
calculated by comparative DDCT method of relative
quantification.
Gene Healthy IR Fold increase (95%-CI) P - value
HIF-1a 1.00 1.91 1.91 (1.15–2.67) 0.02
*
HO-1 1.00 1.58 1.58 (0.22–2.94) 0.34
TNFa 1.00 1.18 1.18 (0.56–1.80) 0.54
IL-6 1.00 12.31 12.31 (25.29229.91) 0.18
IL-8 1.00 15.86 15.86 (0.59–31.13) 0.06
C3 1.00 4.09 4.09 (1.74–6.43) 0.01
*
*p-value#0.05 was considered statistically significant (n=12).
doi:10.1371/journal.pone.0007045.t002
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clearance of apoptotic cells as well as therapeutic strategies to
reduce apoptosis have been shown to be critical in preventing the
mostly harmful IR induced inflammatory response.[2–7,30]
Conclusive data on intestinal ischemia and reperfusion
pathophysiology have been obtained from experimental animal
studies. Cytokine activity of TNFa, IL-6 and IL-8 have been
associated with the inflammatory reaction following IR.[31] As a
prototypic member of the TNF-family, TNF-a is a key mediator of
acute inflammation of which expression is readily induced
following ischemia reperfusion of the small intestine.[32] Interest-
ingly, we did not detect an increase in TNFa message in our
experiments. Similarly, IL-6 was demonstrated as an important
component of the acute phase reaction, able to induce tissue injury
and inflammation following mesenteric ischemia and reperfusion
in IL-6 knockout (KO) mice.[33] IL-6 controls endothelial cell
injury, mediating successive neutrophil influx. Similarly, the
chemokine IL-8 is involved in intestinal ischemia reperfusion
induced inflammation. Administration of an inhibitory anti IL-8
antibody over the course of mesenteric IR in rats prevented
neutrophil infiltration and protected the small intestine from IR
injury.[34] In keeping with these data, Il-6, IL-8 and TNFa gene
expression did not increase in the absence of apoptotic cells, which
were shed into the intestinal lumen immediately upon reperfusion.
E-Selectin (CD-62-E and formerly known as endothelial
leukocyte adhesion molecule-1 (ELAM-1)) has an important role
in the recruitment of leukocytes to sites of tissue injury. Its
expression by vascular endothelial cells in response to injury is
readily induced by cytokines IL-1 and TNFa. Interestingly, our
data suggest that despite initial presence of damaged epithelial cells
in response to an IR period, the rapid shedding of damaged
epithelial debris largely averts endothelial cell activation. Consis-
tent with this observation, PMN infiltration, assessed by total
MPO tissue levels or the presence of HNP1-3 positive cells, in IR
was not detected in our experiments. MPO, most abundantly
released upon PMN activation, has been demonstrated to have a
clear effect on the development of IR induced organ damage.
Renal IR studies have demonstrated that MPO itself is able to
contribute to the development of organ damage.[35]
As a central innate immune regulator, the complement system is
activated during intestinal IR and contributes substantially to IR
induced inflammation, organ damage and failure.[8,9,36] Pre-
venting complement activation has been proven to be beneficial to
organ function after IR in general and intestinal IR more
specifically.[8,12,20] Central in the activation of complement is
the formation of C3a, an anaphylatoxin with the ability to attract
inflammatory cells into the reperfused ischemic tissue. In our
model no deposition of activated C3 in reperfused jejunum was
detected, using immunohistochemical and Western blot analysis.
Interestingly, our results do however suggest C3 gene expression in
healthy jejunum tissue as well as an increased synthesis of C3 in
response to IR. The lack of activated complement components as
well as a clear increase in local C3 mRNA expression levels may
illustrate the intestines response aimed at protection and
preservation. The ability of small intestinal epithelial cells to
express biological mediators such as C3 in response to IR was to
be expected since previous work demonstrated C3 gene expression
in inflamed small intestine.[37] To the best of our knowledge,
however, these are the first results that demonstrate C3 mRNA
expression in the healthy jejunum. Further analysis will have to
elucidate whether increased expression of immune regulatory
proteins is directed at preventing gut barrier bacterial transloca-
tion. However, when faced with massive intestinal barrier failure,
increased expression of immune regulatory proteins able to
prevent gut barrier bacterial translocation might be exceedingly
useful.
The recently discovered molecular mechanism that recognizes
and responds to excessive cell death consisting of SAP130 and the
macrophage inducible C-type lectin (Mincle) fits in our observa-
tions.[38] The loss of excessive numbers of dead cells into the gut
lumen prevents SAP130 released by the dead cells to reach tissue
macrophages thus largely preventing the production of inflamma-
tory cytokines driving rapid neutrophil infiltration. Similarly
activation of complement by dead cells is prevented and maybe
therefore the PMN chemotactic factors C3a en C5a will not be
produced.
A mechanism of protection was suggested by the enhanced
expression of HIF-1a in the surviving epithelium. Expression of
Figure 4. Endothelial activation. Compared to healthy control jejunum tissue, reperfused jejunum samples in response to 30 minutes of ischemia
show an only moderate increase in ICAM-1 (upper panel) and MADCAM-1 (lower panel) expression demonstrated by terracotta red staining of the
AEC (indicated by arrows). Original magnification 200x.
doi:10.1371/journal.pone.0007045.g004
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early reperfusion triggers physiologic responses characterized by
activation of functional proteins mucin, P-glycoprotein, intestinal
trefoil factor and adenosine A2B receptor, aimed at preventing
mucosal inflammation.[39] The role in preserving gut wall
integrity in response to IR as well as the exciting role of HIF-1a
Figure 5. Neutrophil recruitment. A) No increase of PMN was
observed over the course of reperfusion in response to 30 minutes of
ischemia. Detected by specific HNP1-3 staining (AEC, indicated by
arrows) the number of PMN in reperfused jejunum did not increase in
comparison to healthy tissue (p=0.90). Original magnification 200x.
Clearly the PMN concentrated around the cellular debris collecting in
the safe intestinal lumen (right insert in Fig. 4A indicated by arrow.
Original magnification 200x). B) Tissue MPO, assessed by ELISA, did not
increase substantially over the course of IR (p=0.71).
doi:10.1371/journal.pone.0007045.g005
Figure 6. Complement activation. A) C3 was not be detected in the
reperfused jejunum using immunohistochemistry. Original magnifica-
tion 200x. B) Western blot analysis, under reducing conditions, revealed
no increase in activated human C3 (675 kD) in whole reperfused
jejunum samples, when compared to healthy control tissue (p=0.14). C)
C3 mRNA expression increased over 4-fold during IR of the human
jejunum (p=0.01).
doi:10.1371/journal.pone.0007045.g006
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underlines a possibly protective influence of increased HIF-1a
mRNA expression as detected in our model in response to IR of
the human intestine.[39–42]
Taken together, ischemia, sensed by the small intestine, induces
normal physiological and IR induced responses. Our data provide
new and compelling evidence of increased HIF-1a and also C3
gene expression during the reperfusion period. However, these
responses are not paralleled by an IR induced inflammatory
response, since important conditions to an inflammatory reaction
have not been met by the absence of dead cells in the reperfused
tissue. It is important to realize that these data indicate that the
human intestine is more resistant to IR than initially thought. Its
ability to shed damaged epithelial cells and repair its ever
important barrier function without triggering massive inflamma-
tion can be seen as key features that prevent the gut from
inflammation following splanchnic ischemia and reperfusion.
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